111 years of building, sharing and reinvesting in knowledge
1908 in Denmark
Founded and headquartered in Denmark, currently employing 6,000 professionals across 61 countries.
Supplying treatments to people with medical needs in more than 130 countries around the world.
125 million lives
Striving to positively impact the lives of 125 million people through medical dermatology by 2025.
Updates regarding COVID-19
As the COVID-19 situation continues to evolve globally, LEO Pharma is acting to support the health and safety of our employees and to activate our business continuity plans. We stay committed to bring an uninterrupted supply of medicines for patients around the world.Read the full story
LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
LEO Pharma A/S, a global leader in medical dermatology, today announced that is has signed a worldwide exclusive licensing agreement with Oneness Biotech (Taiwan, TPEx: 4743) and Microbio Shanghai (China) covering the development and commercialization of the novel Atopic Dermatitis (AD) and Allergic Asthma drug candidate, FB825.
BALLERUP, Denmark, April 15, 2020Read the full story